Health Care
Commentary
Congress Must Reform The Broken 340B Program
The Trump administration recently announced a $1.6 billion cut to the badly abused “340B” program, which forces pharmaceutical companies to sell medicines to hospitals that treat significant numbers of poor patients at steep discounts. A bipartisan group of senators — including supposed fiscal hawks like Sens. John Thune, R-S.D., and ...
Commentary
Keep Big Government Out of Medicare Drug Pricing Negotiations
Tomorrow, the Senate Health, Education, Labor & Pensions Committee (HELP) will discuss a proposed alteration to Medicare. The proposal comes from a report released in late November by the National Academies of Sciences, Engineering, and Medicine. NASEM urges Congress to allow federal bureaucrats to negotiate Medicare drug prices directly with pharmaceutical companies. Currently, private insurance ...
Commentary
Trump Right To End Obamacare Subsidies
President Trump delivered a surprise to health insurers — he ended billions of dollars in illegal federal payments to them. These payments are Obamacare’s “cost-sharing reduction” subsidies, or CSRs. They’re intended to reimburse insurers for covering out-of-pocket healthcare expenses for certain low-income exchange enrollees. Attorneys general from 18 states and ...
Blog
There’s Plenty To Like About Trump’s HHS Pick, Alex Azar
President Trump’s nomination of Alex Azar for secretary of Health and Human Services is encouraging news for free-market health reformers. Azar possesses precisely the combination of legal acumen, bureaucratic savvy, management experience dealing with a large workforce, and private-sector experience required to eliminate those parts of Obamacare that can be accomplished through ...
Health Care
Azar Pick Signals Regulatory Action on Obamacare
By Erin Durkin The next potential Health and Human Services secretary appears likely to emphasize administrative actions to dismantle Obamacare after congressional Republicans failed to repeal the law this year. Former Eli Lilly and Company executive Alex Azar—who was HHS deputy secretary in the George W. Bush administration— shares former ...
Blog
PRI-Manhattan Institute Forum Addresses California’s Drug Pricing Challenge
Earlier this week, PRI joined with the Manhattan Institute to host a well-attended Sacramento panel discussion on California’s drug pricing challenge. Many thanks to my friend and former longtime Capitol reporter Marcey Brightwell, who did an outstanding job moderating the event. Drug pricing emerged as one of the hottest issues ...
California
California’s Drug Pricing Challenge
Watch a Sacramento panel discussion on California’s drug pricing challenge, co-hosted by PRI and the Manhattan Institute. Moderated by former longtime Capitol journalist Marcey Brightwell, panelists include Dr. Tom Coburn of the Manhattan Institute (and former U.S. Senator from Oklahoma), PRI’s Sally Pipes, and Brett Johnson of the California Life ...
Blog
Maine’s Medicaid Mistake Could Cost Lives
As featured in Kaiser Health News Morning Briefing Maine made history earlier this month by becoming the first state to adopt Obamacare’s Medicaid expansion via ballot initiative. The vote could inspire progressive activists in other states to push for similar referenda. Expanding Medicaid to cover childless, able-bodied adults would blow ...
Health Care
California Shows its Obamacare Support by Outspending U.S. 4-to-1 on Ads
By Ana B. Ibarra and Carmen Heredia Rodriguez The marketing blitz is on. Californians are getting barraged with online pop-up ads, radio spots and television commercials, all aimed at persuading them to sign up for Affordable Care Act health plans during this year’s open-enrollment season. Covered California, the state’s Obamacare ...
Commentary
Bernie, Stop Fibbing About Canada’s Single-Payer Disaster
Late last month, Senator Bernie Sanders traveled to Canada to see firsthand what the United States can “learn” from our northern neighbor’s single-payer healthcare system. The pied piper of single-payer praised the Canadian system profusely, declaring that there is not “any debate” about whether “the quality of care is as ...
Congress Must Reform The Broken 340B Program
The Trump administration recently announced a $1.6 billion cut to the badly abused “340B” program, which forces pharmaceutical companies to sell medicines to hospitals that treat significant numbers of poor patients at steep discounts. A bipartisan group of senators — including supposed fiscal hawks like Sens. John Thune, R-S.D., and ...
Keep Big Government Out of Medicare Drug Pricing Negotiations
Tomorrow, the Senate Health, Education, Labor & Pensions Committee (HELP) will discuss a proposed alteration to Medicare. The proposal comes from a report released in late November by the National Academies of Sciences, Engineering, and Medicine. NASEM urges Congress to allow federal bureaucrats to negotiate Medicare drug prices directly with pharmaceutical companies. Currently, private insurance ...
Trump Right To End Obamacare Subsidies
President Trump delivered a surprise to health insurers — he ended billions of dollars in illegal federal payments to them. These payments are Obamacare’s “cost-sharing reduction” subsidies, or CSRs. They’re intended to reimburse insurers for covering out-of-pocket healthcare expenses for certain low-income exchange enrollees. Attorneys general from 18 states and ...
There’s Plenty To Like About Trump’s HHS Pick, Alex Azar
President Trump’s nomination of Alex Azar for secretary of Health and Human Services is encouraging news for free-market health reformers. Azar possesses precisely the combination of legal acumen, bureaucratic savvy, management experience dealing with a large workforce, and private-sector experience required to eliminate those parts of Obamacare that can be accomplished through ...
Azar Pick Signals Regulatory Action on Obamacare
By Erin Durkin The next potential Health and Human Services secretary appears likely to emphasize administrative actions to dismantle Obamacare after congressional Republicans failed to repeal the law this year. Former Eli Lilly and Company executive Alex Azar—who was HHS deputy secretary in the George W. Bush administration— shares former ...
PRI-Manhattan Institute Forum Addresses California’s Drug Pricing Challenge
Earlier this week, PRI joined with the Manhattan Institute to host a well-attended Sacramento panel discussion on California’s drug pricing challenge. Many thanks to my friend and former longtime Capitol reporter Marcey Brightwell, who did an outstanding job moderating the event. Drug pricing emerged as one of the hottest issues ...
California’s Drug Pricing Challenge
Watch a Sacramento panel discussion on California’s drug pricing challenge, co-hosted by PRI and the Manhattan Institute. Moderated by former longtime Capitol journalist Marcey Brightwell, panelists include Dr. Tom Coburn of the Manhattan Institute (and former U.S. Senator from Oklahoma), PRI’s Sally Pipes, and Brett Johnson of the California Life ...
Maine’s Medicaid Mistake Could Cost Lives
As featured in Kaiser Health News Morning Briefing Maine made history earlier this month by becoming the first state to adopt Obamacare’s Medicaid expansion via ballot initiative. The vote could inspire progressive activists in other states to push for similar referenda. Expanding Medicaid to cover childless, able-bodied adults would blow ...
California Shows its Obamacare Support by Outspending U.S. 4-to-1 on Ads
By Ana B. Ibarra and Carmen Heredia Rodriguez The marketing blitz is on. Californians are getting barraged with online pop-up ads, radio spots and television commercials, all aimed at persuading them to sign up for Affordable Care Act health plans during this year’s open-enrollment season. Covered California, the state’s Obamacare ...
Bernie, Stop Fibbing About Canada’s Single-Payer Disaster
Late last month, Senator Bernie Sanders traveled to Canada to see firsthand what the United States can “learn” from our northern neighbor’s single-payer healthcare system. The pied piper of single-payer praised the Canadian system profusely, declaring that there is not “any debate” about whether “the quality of care is as ...
